共 50 条
- [41] Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12
- [43] The Role of Endoplasmic Reticulum in Lipotoxicity during Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Pathogenesis AMERICAN JOURNAL OF PATHOLOGY, 2023, 193 (12): : 1887 - 1899
- [47] NAFLD vs MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)-Why the Need for a Change of Nomenclature? JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2025,
- [48] Effects of Selected Food Additives on the Gut Microbiome and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) MEDICINA-LITHUANIA, 2025, 61 (02):
- [49] Oral Health Characteristics in US Adults With and Without Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1454 - S1454